跳至主要内容
临床试验/ACTRN12607000326493
ACTRN12607000326493已完成3 期

A randomised controlled trial to determine the optimum frequency of Botulinum Toxin A injections to the calf in children with cerebral palsy

The Royal Children's Hospital, Melbourne, Victoria0 个研究点目标入组 40 人开始时间: 2007年6月19日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
2 Years 至 5 Years(—)
性别
All

入选标准

  • Level I, II, or III on the Gross Motor Function Classification System for cerebral palsyGastrocnemius muscle length greater than 5 degrees with the knee extendedGastrocnemius spasticity (no heel contact during the stance phase of gait)

排除标准

  • Previous Botulinum Toxin A injections to the calf musclePrevious calf surgeryContraindications to the use of Botulinum Toxin A such as known hypersensitivity to any ingredient in the formulation, presence of Myasthenia Gravis or Eaton Lambert syndrome, or the presence of infection at the proposed injection site(s).

研究者

发起方
The Royal Children's Hospital, Melbourne, Victoria

相似试验